Alicia Enrico

6PUBLICATIONS
80CO-AUTHORS
AutoimmunityHaematological tumoursCellular immunologyCancer therapy (excl. chemotherapy and radiation therapy)Cardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 26, 2025
Outcomes After Allogeneic Hematopoietic Cell Transplantation in Adults With Myelodysplastic Syndrome With 65 Years or Older Compared to Youngers. A Retrospective Analysis of the Latin America Registry.

Fernando Barroso Duarte, Yhasmine Delles Oliveira Garcia, Vaneuza Araújo Moreira Funke

|Mar 21, 2025
Evaluation of leukemic stem cell (CD26 +) in chronic myeloid leukemia patients with different molecular responses and in treatment-free remission.

María Fernanda Camacho, Margot Peña, María Jazmín Toloza

|Nov 06, 2024
Immune checkpoints PD1/PDL1, TIM3/GAL9 and key immune mediators landscape reveal differential expression dynamics on imatinib response in chronic myeloid leukemia.

María Jazmín Toloza, Marco Lincango, María Fernanda Camacho

|Aug 25, 2023
Updated quality of life data from the phase 3b VENICE II trial: patients with relapsed or refractory chronic lymphocytic leukemia receiving venetoclax monotherapy.

Tara Cochrane, Alicia Enrico, David Gomez-Almaguer

|Nov 02, 2021
COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study.

Thomas Chatzikonstantinou, Anargyros Kapetanakis, Lydia Scarfò

|Oct 11, 2021
Impact of venetoclax monotherapy on the quality of life of patients with relapsed or refractory chronic lymphocytic leukemia: results from the phase 3b VENICE II trial.

Tara Cochrane, Alicia Enrico, David Gomez-Almaguer

Pageof 1

Frequent Collaborators

2 joint publications

Tara Cochrane

2 joint publications

David Gomez-Almaguer

2 joint publications

Eugene Nikitin

2 joint publications

Tadeusz Robak